Alterity Therapeutics Limited ATHE
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 25.82M | 25.61M | 32.82M | 32.54M | 26.66M |
| Total Receivables | 5.33M | 5.28M | 4.56M | 4.53M | 2.58M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 532.00K | 527.80K | -- | -- | 808.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 29.60K | 29.40K | 520.30K | 515.90K | 27.40K |
| Total Current Assets | 31.70M | 31.45M | 37.90M | 37.58M | 30.07M |
|
|
|||||
| Total Current Assets | 31.70M | 31.45M | 37.90M | 37.58M | 30.07M |
| Net Property, Plant & Equipment | 131.80K | 130.80K | 64.00K | 63.40K | 101.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 31.84M | 31.58M | 37.97M | 37.65M | 30.18M |
|
|
|||||
| Total Accounts Payable | 774.20K | 768.10K | 1.06M | 1.06M | 352.90K |
| Total Accrued Expenses | 1.33M | 1.32M | 627.00K | 621.70K | 1.90M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 38.20K | 37.90K | 22.00K | 21.80K | 43.90K |
| Total Finance Division Other Current Liabilities | 45.40K | 45.00K | 10.70K | 10.60K | 23.40K |
| Total Other Current Liabilities | 45.40K | 45.00K | 10.70K | 10.60K | 23.40K |
| Total Current Liabilities | 2.18M | 2.17M | 1.72M | 1.71M | 2.32M |
|
|
|||||
| Total Current Liabilities | 2.18M | 2.17M | 1.72M | 1.71M | 2.32M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 95.70K | 94.90K | 43.70K | 43.30K | 58.10K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 0.00 |
| Total Liabilities | 2.28M | 2.26M | 1.77M | 1.75M | 2.38M |
|
|
|||||
| Common Stock & APIC | 195.44M | 193.89M | 188.44M | 186.86M | 172.39M |
| Retained Earnings | -169.90M | -168.55M | -156.34M | -155.02M | -148.09M |
| Treasury Stock & Other | 4.01M | 3.98M | 4.09M | 4.06M | 3.50M |
| Total Common Equity | 29.56M | 29.32M | 36.20M | 35.89M | 27.80M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 29.56M | 29.32M | 36.20M | 35.89M | 27.80M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 29.56M | 29.32M | 36.20M | 35.89M | 27.80M |
|
|
|||||